AxoGen Statistics
Share Statistics
AxoGen has 44.01M shares outstanding. The number of shares has increased by 1.86% in one year.
| Shares Outstanding | 44.01M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.41% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 41.54M |
| Failed to Deliver (FTD) Shares | 24 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 1.01M, so 2.31% of the outstanding shares have been sold short.
| Short Interest | 1.01M |
| Short % of Shares Out | 2.31% |
| Short % of Float | 2.44% |
| Short Ratio (days to cover) | 4.26 |
Valuation Ratios
The PE ratio is -13.49 and the forward PE ratio is 42.81.
| PE Ratio | -13.49 |
| Forward PE | 42.81 |
| PS Ratio | 1.84 |
| Forward PS | 3.4 |
| PB Ratio | 3.06 |
| P/FCF Ratio | -14.19 |
| PEG Ratio | n/a |
Enterprise Valuation
AxoGen Inc. has an Enterprise Value (EV) of 325.13M.
| EV / Earnings | -14.97 |
| EV / Sales | 2.04 |
| EV / EBITDA | -24.39 |
| EV / EBIT | -15.15 |
| EV / FCF | -15.76 |
Financial Position
The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.49.
| Current Ratio | 2.89 |
| Quick Ratio | 2.14 |
| Debt / Equity | 0.49 |
| Total Debt / Capitalization | 32.76 |
| Cash Flow / Debt | -0.12 |
| Interest Coverage | -7.57 |
Financial Efficiency
Return on equity (ROE) is -0.23% and return on capital (ROIC) is -13.01%.
| Return on Equity (ROE) | -0.23% |
| Return on Assets (ROA) | -0.11% |
| Return on Capital (ROIC) | -13.01% |
| Revenue Per Employee | 373.27K |
| Profits Per Employee | -50.98K |
| Employee Count | 426 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.35 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 129.31% in the last 52 weeks. The beta is 1.13, so AxoGen 's price volatility has been higher than the market average.
| Beta | 1.13 |
| 52-Week Price Change | 129.31% |
| 50-Day Moving Average | 14.7 |
| 200-Day Moving Average | 10.92 |
| Relative Strength Index (RSI) | 67.47 |
| Average Volume (20 Days) | 405.03K |
Income Statement
In the last 12 months, AxoGen had revenue of 159.01M and earned -21.72M in profits. Earnings per share was -0.51.
| Revenue | 159.01M |
| Gross Profit | 127.87M |
| Operating Income | -21.46M |
| Net Income | -21.72M |
| EBITDA | -13.33M |
| EBIT | -21.46M |
| Earnings Per Share (EPS) | -0.51 |
Balance Sheet
The company has 31.02M in cash and 69.29M in debt, giving a net cash position of -38.27M.
| Cash & Cash Equivalents | 31.02M |
| Total Debt | 69.29M |
| Net Cash | -38.27M |
| Retained Earnings | -281.30M |
| Total Assets | 191.99M |
| Working Capital | 63.22M |
Cash Flow
In the last 12 months, operating cash flow was -5.72M and capital expenditures -14.92M, giving a free cash flow of -20.63M.
| Operating Cash Flow | -5.72M |
| Capital Expenditures | -14.92M |
| Free Cash Flow | -20.63M |
| FCF Per Share | -0.48 |
Margins
Gross margin is 80.42%, with operating and profit margins of -13.5% and -13.66%.
| Gross Margin | 80.42% |
| Operating Margin | -13.5% |
| Pretax Margin | -13.66% |
| Profit Margin | -13.66% |
| EBITDA Margin | -8.38% |
| EBIT Margin | -13.5% |
| FCF Margin | -12.98% |
Dividends & Yields
AXGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2.8% |
| FCF Yield | -2.57% |
Analyst Forecast
The average price target for AXGN is $14, which is -23.2% lower than the current price. The consensus rating is "Buy".
| Price Target | $14 |
| Price Target Difference | -23.2% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Jul 11, 1994. It was a backward split with a ratio of 20:21.
| Last Split Date | Jul 11, 1994 |
| Split Type | backward |
| Split Ratio | 20:21 |
Scores
| Altman Z-Score | 3.26 |
| Piotroski F-Score | 3 |